Iridian Asset Management LLC Halozyme Therapeutics, Inc. Transaction History

Iridian Asset Management LLC

$446 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$25.81 - $43.62 $1 Million - $1.7 Million	-38,906 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$25.74 - $29.63 $563,706 - $648,897	-21,900 Reduced 36.02%	38,906 $1.02 Million
Q2 2020 Aug 10, 2020	SELL	$16.25 - $26.81 $449,068 - $740,894	-27,635 Reduced 31.25%	60,806 $1.63 Million
Q1 2020 May 11, 2020	SELL	$13.9 - $21.83 $271,911 - $427,038	-19,562 Reduced 18.11%	88,441 $1.59 Million
Q4 2019 Feb 03, 2020	SELL	$14.93 - $19.53 $65 Million - $85 Million	-4,354,430 Reduced 97.58%	108,003 $1.92 Million
Q3 2019 Nov 06, 2019	SELL	$15.2 - $17.69 $5.91 Million - $6.88 Million	-388,796 Reduced 8.01%	4,462,433 $69.2 Million
Q2 2019 Jul 31, 2019	SELL	$14.75 - $17.26 $31.8 Million - $37.3 Million	-2,158,837 Reduced 30.8%	4,851,229 $83.3 Million
Q1 2019 May 06, 2019	SELL	$13.94 - $17.58 $28.1 Million - $35.5 Million	-2,017,098 Reduced 22.34%	7,010,066 $113 Million
Q4 2018 Feb 07, 2019	SELL	$13.33 - $18.66 $2.68 Million - $3.76 Million	-201,235 Reduced 2.18%	9,027,164 $132 Million
Q3 2018 Nov 09, 2018	BUY	$16.68 - $18.41 $16.1 Million - $17.8 Million	967,923 Added 11.72%	9,228,399 $168 Million
Q2 2018 Aug 01, 2018	BUY	$16.87 - $20.3 $1.15 Million - $1.38 Million	68,098 Added 0.83%	8,260,476 $139 Million
Q1 2018 May 10, 2018	SELL	$17.06 - $21.2 $9.94 Million - $12.4 Million	-582,695 Reduced 6.64%	8,192,378 $160 Million
Q4 2017 Feb 01, 2018	SELL	$16.75 - $20.8 $20.6 Million - $25.6 Million	-1,230,879 Reduced 12.3%	8,775,073 $178 Million
Q3 2017 Nov 08, 2017	SELL	$11.76 - $17.4 $7.09 Million - $10.5 Million	-603,041 Reduced 5.68%	10,005,952 $174 Million
Q2 2017 Aug 07, 2017	BUY	N/A	10,608,993	10,608,993 $136 Million

Others Institutions Holding HALO

# of Institutions

542

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$930 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$681 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$350 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$215 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$180 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Iridian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iridian Asset Management LLC with notifications on news.

Account